ClinicalTrials.Veeva

Menu

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas (GAMMA)

S

Sklifosovsky Institute of Emergency Care

Status

Suspended

Conditions

Metastases to Brain
Gliomas Benign
Glioma, Malignant

Treatments

Procedure: Tumor resection in asleep patient
Procedure: Tumor resection in awake patient

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

Full description

Awake surgery is usually used for tumor resection located in language areas. But patient's awakening during removal of mass lesions from motor areas can give additional opportunities. Besides checking of muscle contractions and integrity of motor fibers a surgeon in awake patient can assess planning of movements, praxis, visual feedback and vestibular processing of motions. Preserving of voluntary movements can be an additional proof that cortical motor centers and corticospinal tract were not damaged. At the moment there are no published results of randomized trials showing advantage of awake surgery in removal of mass lesions from motor brain areas.

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

Participants of the study will be randomly operated using awake surgery or general anesthesia. In both groups intraoperative neuromonitoring will be used. Dynamics of motor functions will be assessed before and after surgery by blinded neurologists.

Enrollment

72 estimated patients

Sex

All

Ages

18 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • single gliomas without contrast enhancement in preoperative magnetic resonance imaging (presumed low-grade gliomas)
  • single gliomas with contrast enhancement in preoperative magnetic resonance imaging (presumed high-grade gliomas)
  • one or several brain metastases from any cancer
  • location near primary motor area or corticospinal tract
  • newly diagnosed
  • Karnofsky Performance Status 60-100%
  • muscle strength in assessed limbs 3-5 points in Medical Research Council scale
  • age 18-69 years
  • body mass index 29 and less
  • hemoglobin 110 and more
  • platelets 100 and more
  • international normalized ratio less than 2,0
  • presumed blood loss no more than 8-10 percents of circulating blood volume (no more than 450-650 milliliters)

Exclusion criteria

  • chronic obstructive pulmonary disease
  • persistent smoker (smoking index 11 and more)
  • major comorbidities
  • implanted pacemaker
  • inability to perform intraoperative tests before surgery
  • severe aphasia
  • psychiatric disorders
  • barely controlled seizures
  • contraindications to magnetic resonance imaging
  • previously performed brain radiotherapy
  • pregnancy
  • breast feeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

72 participants in 2 patient groups

Awake surgery
Experimental group
Description:
Critical steps of brain mapping and tumor removal will be performed in awake patient
Treatment:
Procedure: Tumor resection in awake patient
General anesthesia
Active Comparator group
Description:
Brain mapping and tumor removal will be performed in asleep patient
Treatment:
Procedure: Tumor resection in asleep patient

Trial contacts and locations

1

Loading...

Central trial contact

Alexander Dmitriev, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems